Skip to main content
Signal8
Launch Terminal

Stereotaxis, Inc. (STXS)

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

Sector: Electromedical & Electrotherapeutic Apparatus

Industry: Medical - Instruments & Supplies

Stereotaxis, Inc. logo

Stereotaxis, Inc.

NYSE:STXSHealthcare
+2.20%$1.02
AH Close$1.02+0.00%vs close
Mkt Cap$102.21M
Float80.94M
O/S100.2M
Inst Own41.3%
SI7.0%
Dilution
Stereotaxis, Inc. logoNYSE:STXS$1.02+2.20%
FormDescription
13G
Beneficial Ownership Report
1
EFFECT
Notice of Effectiveness
EFFECT
Notice of Effectiveness
424B3
Prospectus
6
424B3
Prospectus
5
10-Q
Quarterly Report
7
8-K
2.02,9.01
5
8-K
8.01,9.01
S-3
Shelf Registration Statement
3
S-3
Shelf Registration Statement
5
8-K
3.02,7.01,8.01,9.01
3
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
SD
SEC Filing
13G/A
Beneficial Ownership Report (Amended)
8-K
5.07
10-Q
Quarterly Report
3
8-K
2.02,9.01
2
8-K
1.01,3.02,7.01,9.01
4
Statement of Changes in Beneficial Ownership
10-K/A
Annual Report (Amended)

1-25 of 1,554

…
    Stereotaxis, Inc. (STXS) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8